Use of Non-invasive Ventilation in Motor Neuron Disease – A Retrospective Cohort Analysis
| Autor: | Desmond M. Murphy, Kevin F. Deasy, Elizabeth O’Sullivan, Aisling M. Ryan, Laura J. Walsh, Fernando Gomez, Joseph A. Eustace |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Pulmonary and Respiratory Medicine medicine.medical_specialty Disease pulmonary function tests Pulmonary function testing Cohort Studies Quality of life Internal medicine medicine Respiratory muscle Humans Motor Neuron Disease Retrospective Studies Original Paper Noninvasive Ventilation business.industry non-invasive ventilation respiratory failure Retrospective cohort study Respiration Artificial Respiratory failure Cohort Quality of Life Breathing Respiratory Insufficiency business |
| Zdroj: | Chronic Respiratory Disease |
| DOI: | 10.21203/rs.3.rs-657662/v1 |
| Popis: | Background Motor neuron disease (MND) is a neurodegenerative disorder which leads to progressive muscle weakness including respiratory muscle function decline. The introduction of non-invasive ventilation (NIV) has been shown to improve quality of life, survival and slow the rate of pulmonary function decline. Better compliance with the machine (using it for greater than 4 hours per day) has been shown to have the greatest long-term benefit. Methods A retrospective chart analysis of patients who attended the MND clinic from 2014-2019 at a tertiary-referral, academic, teaching hospital was carried out to evaluate if NIV and greater compliance with NIV was associated with improved survival. Information regarding NIV use, compliance, pulmonary function tests (PFTs) and basic patient demographics was collected. In total 111 patients were included in the study. Results The mean age at diagnosis was 63.8 years and 61.3% were males. 66.7% of our patient cohort used NIV and of this 44.1% were compliant. There was a statistically significant longer survival in those who used NIV (P=0.002) and in those who used NIV optimally (P=0.02) when both groups were compared to those who did not use NIV. In the bulbar MND group those who were compliant with NIV survived longer than who those who did not use NIV (P=0.001). Patients with bulbar onset MND had worse SNIP and peak cough flow values at diagnosis.Conclusion We found a significantly longer survival with the use of NIV, the use of NIV optimally and with use of NIV in those with bulbar onset MND compared to those who did not use NIV. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|